In a homocysteine-induced cognitive impairment model, an independent risk factor for AD, betaine alleviated cognitive impairment by inhibiting the NLRP3/caspase-1/GSDMD pathway in an m6A-YTHDF2-dependent manner, thereby suppressing microglial pyroptosis (187). The gene discussed is CASP1; the disease is Cognitive impairment.